BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Avian flu virus, Vitamin E, rs6983267, TGFB1, Response to oxidative stress, Influenza)
Bookmark Forward

QuickView for prazosin (compound)


Genetic Markers

Most Correlated Genes

  1. ADRA1A
  2. MAG
  3. HLA-DQB1
  4. MT1A
  5. OXTR
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. regulation of phosphorus metabolic process
  2. response to organic substance
  3. regulation of nitrogen compound metabolic process
  4. PILON_KLF1_TARGETS_DN
  5. organic cyclic compound binding
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Livers of CD-1 mice treated with genotoxic, non-genotoxic or non-hepatocarcinogens
  2. Hepatocyte cells of Wistar rats treated with 29 different hepatotoxic compounds
  3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
  4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
  5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Prospective evaluation of pregnancy outcomes after gestational exposure to prazosin.
  2. Prazosin for nightmares in serious illness.
  3. Prazosin administration increases the rate of recurrent urethral obstruction in cats: 388 cases.
  4. A randomized controlled clinical trial of prazosin for alcohol use disorder in active duty soldiers:…
  5. The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartmen…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Prazosin for ETOH or Cocaine Craving
  2. Prazosin for Post-Concussive Headaches
  3. Prazosin for Agitation in Alzheimer's Disease
  4. Varenicline + Prazosin for Heavy Drinking Smokers
  5. AScVS and/ or Prazosin for Scorpion Envenomation
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.